Pirfenidone stabilizes pulmonary function and reduces 18F-FDG-uptake in restrictive allograft syndrome following lung transplantation

R. Vos, S. Verleden, D. Ruttens, E. Vandermeulen, H. Bellon, J. Yserbyt, L. Dupont, O. Gheysens, N. De Raedt, D. Van Raemdonck, B. Vanaudenaerde, G. Verleden (Leuven, Belgium)

Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Session: Post-transplant complications: from pathogenesis to treatment
Session type: Poster Discussion
Number: 3322
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Vos, S. Verleden, D. Ruttens, E. Vandermeulen, H. Bellon, J. Yserbyt, L. Dupont, O. Gheysens, N. De Raedt, D. Van Raemdonck, B. Vanaudenaerde, G. Verleden (Leuven, Belgium). Pirfenidone stabilizes pulmonary function and reduces 18F-FDG-uptake in restrictive allograft syndrome following lung transplantation. Eur Respir J 2014; 44: Suppl. 58, 3322

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Assessment of the restrictive allograft syndrome in patients after lung transplantation
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012

The effect of everolimus on lung function and renal status in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

Predictive factors of restrictive allograft syndrome after lung-transplantation
Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes
Year: 2014

Progressive TLC loss after unilateral lung transplantation in IPF: Functional respiratory imaging differentiates between transplanted and native lung
Source: International Congress 2015 – A more functional view of chest pathology
Year: 2015

Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD)
Source: International Congress 2018 – Rare lung diseases
Year: 2018


Effects of transplantation on lung and exercise physiology
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=220
Year: 2003

Paediatric lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=243
Year: 2003

Paediatric lung transplantation
Source: Eur Respir J 2004; 24 : 839-845
Year: 2004



Pulmonary function and respiratory complications in hematopoietic cell transplant
Source: International Congress 2016 – Quality and quantity in lung function
Year: 2016


Lung transplantation for pulmonary fibrosis
Source: International Congress 2015 – Lung transplantation in the year 2015: current indications and results
Year: 2015



Lung function tests and survival in idiopathic pulmonary fibrosis after lung transplantation
Source: Eur Respir J 2005; 26: Suppl. 49, 335s
Year: 2005

Lung transplantation for pulmonary hypertension
Source: Eur Respir Mon 2012; 57: 247-255
Year: 2012


Pulmonary function changes following allogeneic haematopoietic cell transplantation
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016


Orthotopic lung transplantation in a single-mismatch-based mouse model shows signs of chronic lung allograft dyfunction (CLAD)
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

Obstructive and restrictive pulmonary function defect after chronic GVHD and lung transplantation: a pathologist’s view
Source: International Congress 2016 – Chronic graft-versus-host disease and chronic allograft dysfunction after lung transplantation: similarities and dissimilarities
Year: 2016


Predictive value of donor age for recipient lung function and CLAD-free survival after lung transplantation
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015

The impact of underlying disease on baseline pulmonary function values after lung transplantation
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016


Lung transplantation: the ideal treatment for diffuse disease?
Source: Annual Congress 2006 - Up to date management of bronchiectasis
Year: 2006


Analysis of factors affecting pretransplant pulmonary function tests and impact on overall survival after allogenic stem cell transplantation
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015

Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013